United States

Proteon Therapeutics Inc (PRTO.OQ)

PRTO.OQ on NASDAQ Stock Exchange Global Market

12:26pm EST
Change (% chg)

$0.07 (+3.98%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Paul Hastings

58 2016 Chairman of the Board

Timothy Noyes

55 2006 President, CEO, Director

George Eldridge

54 2013 Chief Financial Officer, Senior Vice President, Treasurer, Assistant Secretary, IR Contact Officer

E. Scott Toner

62 2015 Senior Vice President - Marketing

Steven Burke

56 2006 Senior Vice President, Chief Medical Officer